S&P 500   3,136.63 (+0.02%)
DOW   27,903.39 (-0.02%)
QQQ   204.45 (+0.19%)
AAPL   269.43 (+0.94%)
FB   200.99 (-0.17%)
MSFT   151.54 (+0.12%)
GOOGL   1,345.01 (+0.15%)
AMZN   1,741.09 (-0.48%)
NVDA   215.00 (+1.33%)
MU   47.70 (+2.67%)
BABA   201.29 (+1.28%)
GE   11.00 (+0.00%)
TSLA   349.81 (+3.03%)
T   38.20 (+0.42%)
AMD   39.69 (+1.95%)
F   9.09 (+0.89%)
PRI   135.36 (+0.00%)
NFLX   297.53 (-1.64%)
BAC   33.49 (-0.06%)
GILD   66.96 (+0.04%)
S&P 500   3,136.63 (+0.02%)
DOW   27,903.39 (-0.02%)
QQQ   204.45 (+0.19%)
AAPL   269.43 (+0.94%)
FB   200.99 (-0.17%)
MSFT   151.54 (+0.12%)
GOOGL   1,345.01 (+0.15%)
AMZN   1,741.09 (-0.48%)
NVDA   215.00 (+1.33%)
MU   47.70 (+2.67%)
BABA   201.29 (+1.28%)
GE   11.00 (+0.00%)
TSLA   349.81 (+3.03%)
T   38.20 (+0.42%)
AMD   39.69 (+1.95%)
F   9.09 (+0.89%)
PRI   135.36 (+0.00%)
NFLX   297.53 (-1.64%)
BAC   33.49 (-0.06%)
GILD   66.96 (+0.04%)
S&P 500   3,136.63 (+0.02%)
DOW   27,903.39 (-0.02%)
QQQ   204.45 (+0.19%)
AAPL   269.43 (+0.94%)
FB   200.99 (-0.17%)
MSFT   151.54 (+0.12%)
GOOGL   1,345.01 (+0.15%)
AMZN   1,741.09 (-0.48%)
NVDA   215.00 (+1.33%)
MU   47.70 (+2.67%)
BABA   201.29 (+1.28%)
GE   11.00 (+0.00%)
TSLA   349.81 (+3.03%)
T   38.20 (+0.42%)
AMD   39.69 (+1.95%)
F   9.09 (+0.89%)
PRI   135.36 (+0.00%)
NFLX   297.53 (-1.64%)
BAC   33.49 (-0.06%)
GILD   66.96 (+0.04%)
S&P 500   3,136.63 (+0.02%)
DOW   27,903.39 (-0.02%)
QQQ   204.45 (+0.19%)
AAPL   269.43 (+0.94%)
FB   200.99 (-0.17%)
MSFT   151.54 (+0.12%)
GOOGL   1,345.01 (+0.15%)
AMZN   1,741.09 (-0.48%)
NVDA   215.00 (+1.33%)
MU   47.70 (+2.67%)
BABA   201.29 (+1.28%)
GE   11.00 (+0.00%)
TSLA   349.81 (+3.03%)
T   38.20 (+0.42%)
AMD   39.69 (+1.95%)
F   9.09 (+0.89%)
PRI   135.36 (+0.00%)
NFLX   297.53 (-1.64%)
BAC   33.49 (-0.06%)
GILD   66.96 (+0.04%)
Log in

NASDAQ:VRNM - Verenium Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume240,414 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:VRNM
CUSIPN/A
WebN/A
Phone+1-858-4318500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive VRNM News and Ratings via Email

Sign-up to receive the latest news and ratings for VRNM and its competitors with MarketBeat's FREE daily newsletter.


Verenium (NASDAQ:VRNM) Frequently Asked Questions

What is Verenium's stock symbol?

Verenium trades on the NASDAQ under the ticker symbol "VRNM."

Has Verenium been receiving favorable news coverage?

News articles about VRNM stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Verenium earned a daily sentiment score of 1.2 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Verenium.

Who are Verenium's key executives?

Verenium's management team includes the folowing people:
  • James H. Cavanaugh Ph.D., Independent Chairman of the Board (Age 77)
  • James E. Levine, President, Chief Executive Officer, Director (Age 43)
  • Jeffrey G. Black, Chief Financial Officer, Senior Vice President (Age 48)
  • Janet S. Roemer, Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit (Age 57)
  • Alexander A. Fitzpatrick, Senior Vice President, General Counsel, Secretary (Age 47)
  • John F. Dee, Independent Director (Age 56)
  • Peter R Johnson, Independent Director (Age 61)
  • Fernand J. Kaufmann, Independent Director (Age 70)
  • Holger A. Liepmann, Independent Director (Age 63)
  • Joshua Ruch, Independent Director

How can I contact Verenium?

Verenium's mailing address is 3550 John Hopkins Ct, SAN DIEGO, CA 92121-1121, United States. The biotechnology company can be reached via phone at +1-858-4318500.


MarketBeat Community Rating for Verenium (NASDAQ VRNM)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  270
MarketBeat's community ratings are surveys of what our community members think about Verenium and other stocks. Vote "Outperform" if you believe VRNM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRNM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Featured Article: Support Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel